Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-08

FDA Approved: ISOTRETINOIN — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for isotretinoin from Actavis Pharma, Inc., resulting in changes to the product labeling under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

SUPPL AP for ISOTRETINOIN (ISOTRETINOIN)